Uniquire Stock Price (NASDAQ:QURE)

Add to My Stocks
$25.45 $0.83 (3.37%) QURE stock closing price Feb 21, 2018 (Closing)
Prev Close* : $24.62
Market Cap:
$758.3M
Day Low: $24.36
52 Week Low: $4.72
Open: $24.6
Volume: -
Day High: $26.45
52 Week High: $26.45
Dividend:
0.00

Latest Stock Market News

Latest Articles

Uniquire News - From Partners

QURE Stockcharts

View QURE PE ratio, PS ratio stocks charts and compare with peers.
QURE Chart
Note: Compare Uniquire stock price history with the index and industry peers.

Uniquire Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
33.2
PB ratio (
price to book ratio
)
13.76

Uniquire Returns

ROE
(return on equity)
-140%

Uniquire Financial Ratios

Asset Turnover
0.06
Receivables Turnover
3.33
Debt to Equity
1.05
Dividend Yield
0%

QURE Industry Peers

Company Price Change (%)
Ani Pharma (ANIP)57.940.2 (0.35%)
Urogen Pharma (URGN)50.930.93 (1.86%)
Amgen (AMGN)182.430.55 (0.3%)
Dimension Therapeutics (DMTX)5.950 (0%)
Sangamo Therap (SGMO)22.20.05 (0.22%)
Spark Therapeutics (ONCE)51.341.11 (2.21%)
Ionis Pharma (IONS)49.860.13 (0.26%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Fate Therapeutics (FATE)10.591.42 (15.49%)
NeoGenomics (NEO)8.080.72 (9.78%)
Sunesis Pharma (SNSS)6.990.62 (9.73%)
Compugen (CGEN)3.250.2 (6.56%)
Fortress Biotech (FBIO)3.630.21 (6.14%)
Alder BioPharma (ALDR)14.550.7 (5.05%)
Stemline Therapeutics (STML)16.550.75 (4.75%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 22, 2018
CompanyPriceChange (%)
GTx (GTXI)15.461.25 (7.48%)
Catalyst Biosciences (CBIO)27.541.96 (6.64%)
Five Prime Therapeutics (FPRX)17.681.21 (6.41%)
Arbutus Biopharma (ABUS)5.250.25 (4.55%)
Ultragenyx Pharma (RARE)46.311.87 (3.88%)
MediciNova (MNOV)10.610.4 (3.63%)
The Medicines Company (MDCO)31.621.18 (3.6%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 22, 2018

Uniqure NV Stock News - Partner Headlines

Uniquire Financial Statements

income statement20162015201420132012
Net Sales or Revenues25.09M10.46M6.22M3.9M-
Net Income-73.37M-79.37M-49.21M-35.62M-18.92M
Total Operating Expense97.04M85.8M51.17M32.94M19.01M
View Uniquire income statement
balance sheet20162015201420132012
Total Assets190.26M268.83M127.28M51.76M7.15M
Total Liabilities126.63M136.15M70.03M44.37M7.73M
Shareholders Equity63.63M132.67M57.25M7.39M-0.57M
View Uniquire balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-10.29M69.25M1.34M18.71M-
Net Cash from (used by) Operating Activities-72.18M19.07M-33.78M-5.49M-14.5M
Increase (Decrease) in Prop Plant And Equipment-15.28M-6.29M-20.95M-1.77M-0.5M
View Uniquire cash flow statement

Uniquire Stock Message Board

An investor needs to spend $25.45 to buy QURE stock, as the closing Uniquire stock price is $25.45. The total market value as denoted by $758.3M for Uniquire, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform Uniquire valuation, even though in the short-term, sentiment and current breaking news might affect Uniquire stock price.

Demand for a stock decides its stock market price. For example, if more investors want to buy QURE stock than sell it, then Uniquire stock price goes up. Conversely, if more investors wanted to sell QURE stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Uniquire stock quote data shows the number of shares traded. For Ex: 400,103 Uniquire shares were traded as of last trading day, as seen from Uniquire stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Uniquire dividend per share was 0.00 during the last quarter. Uniquire stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.